PL318501A1 - Pharmaceutic compositions containing a tnc bonding chimeric protein - Google Patents

Pharmaceutic compositions containing a tnc bonding chimeric protein

Info

Publication number
PL318501A1
PL318501A1 PL95318501A PL31850195A PL318501A1 PL 318501 A1 PL318501 A1 PL 318501A1 PL 95318501 A PL95318501 A PL 95318501A PL 31850195 A PL31850195 A PL 31850195A PL 318501 A1 PL318501 A1 PL 318501A1
Authority
PL
Poland
Prior art keywords
tnc
bonding
compositions containing
chimeric protein
pharmaceutic compositions
Prior art date
Application number
PL95318501A
Inventor
Robert Fredrick Geoffrey Booth
Werner Lesslauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL318501A1 publication Critical patent/PL318501A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
PL95318501A 1994-07-22 1995-07-15 Pharmaceutic compositions containing a tnc bonding chimeric protein PL318501A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94111455 1994-07-22
PCT/EP1995/002788 WO1996003141A1 (en) 1994-07-22 1995-07-15 Pharmaceutical compositions comprising a chimaeric tnf binding protein

Publications (1)

Publication Number Publication Date
PL318501A1 true PL318501A1 (en) 1997-06-23

Family

ID=8216138

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95318501A PL318501A1 (en) 1994-07-22 1995-07-15 Pharmaceutic compositions containing a tnc bonding chimeric protein

Country Status (11)

Country Link
EP (1) EP0772449A1 (en)
JP (1) JPH09508140A (en)
AU (1) AU3111995A (en)
BR (1) BR9508419A (en)
CA (1) CA2195665A1 (en)
CZ (1) CZ283219B6 (en)
FI (1) FI970247A0 (en)
HU (1) HUT76666A (en)
NO (1) NO970264L (en)
PL (1) PL318501A1 (en)
WO (1) WO1996003141A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6350730B1 (en) 1994-08-17 2002-02-26 The Rockefeller University OB polypeptides and modified forms as modulators of body weight
US6471956B1 (en) 1994-08-17 2002-10-29 The Rockefeller University Ob polypeptides, modified forms and compositions thereto
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6429290B1 (en) 1994-08-17 2002-08-06 The Rockefeller University OB polypeptides, modified forms and derivatives
US6936439B2 (en) 1995-11-22 2005-08-30 Amgen Inc. OB fusion protein compositions and methods
US20030040467A1 (en) 1998-06-15 2003-02-27 Mary Ann Pelleymounter Ig/ob fusions and uses thereof.
HRP970224A2 (en) * 1996-05-08 1998-04-30 Hoffmann La Roche TREATMENT OF ASTHMA WITH TNFR-Ig
TW555765B (en) * 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
EP0948543A1 (en) * 1996-12-12 1999-10-13 Genentech, Inc. Hvem polypeptides and uses thereof
MXPA01005267A (en) 1998-11-27 2002-04-24 Synaptics Uk Ltd Position sensor.
EE200300408A (en) * 2001-02-23 2003-12-15 Immunex Corporation Increasing the yield of active proteins
WO2003011323A1 (en) * 2001-07-30 2003-02-13 Genset S.A. Agonists and antagonists of contabix for use in the treatment of metabolic disorders
US7786282B2 (en) 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
WO2003066165A1 (en) 2002-02-06 2003-08-14 Ares Trading S.A. Tumor necrosis factor combined with interferon in demyelinating diseases
US7928205B2 (en) 2004-10-22 2011-04-19 Amgen Inc. Methods for refolding of recombinant antibodies
EP3191131A4 (en) 2014-08-21 2018-09-05 The General Hospital Corporation Tumor necrosis factor superfamily and tnf-like ligand muteins and methods of preparing and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98078A0 (en) * 1991-05-07 1992-06-21 Yeda Res & Dev Pharmaceutical compositions comprising an anticytokyne
ATE194384T1 (en) * 1989-09-12 2000-07-15 Hoffmann La Roche TNF-BINDING PROTEINS
GB9015908D0 (en) * 1990-07-19 1990-09-05 Celltech Ltd Multivalent immunoglobulin
KR100232688B1 (en) * 1992-09-15 1999-12-01 스코트 쥐. 홀퀴스트 Pharmaceutical compositions for treating tnf-dependent inflammation using tumor necrosis factor antagonists
WO1994008609A1 (en) * 1992-10-15 1994-04-28 Dana-Farber Cancer Institute, Inc. TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION

Also Published As

Publication number Publication date
NO970264L (en) 1997-03-24
FI970247A (en) 1997-01-21
CZ19397A3 (en) 1997-06-11
WO1996003141A1 (en) 1996-02-08
HUT76666A (en) 1997-10-28
BR9508419A (en) 1997-11-18
NO970264D0 (en) 1997-01-21
JPH09508140A (en) 1997-08-19
CA2195665A1 (en) 1996-02-08
CZ283219B6 (en) 1998-02-18
FI970247A0 (en) 1997-01-21
AU3111995A (en) 1996-02-22
EP0772449A1 (en) 1997-05-14

Similar Documents

Publication Publication Date Title
AU2398395A (en) Delayed-release encapsulated warewashing composition
PL316040A1 (en) Pharmaceutic compositions
PL318501A1 (en) Pharmaceutic compositions containing a tnc bonding chimeric protein
PL325598A1 (en) Deriphenacin containing pharmaceutic preparation
AU1178995A (en) Liquid cleaning compositions
AU1209295A (en) Liquid cleaning compositions
EP0690122A3 (en) Detergent compositions
EP0754227A4 (en) Chimeric complement inhibitor proteins
AU1559995A (en) Soldering composition
PL320228A1 (en) Liquid cleaning compositions
AU3534793A (en) Machine dishwashing composition
ZA954521B (en) Dishwashing compositions
AU7263598A (en) Liquid cleaning compositions
AU1894795A (en) Detergent compositions
GB9414105D0 (en) Liquid detergent compositions
AU2866895A (en) Detergent compositions
IL111660A0 (en) Chimeric oligonucleoside compounds
AU2763395A (en) Cleaning compositions
AU3626989A (en) Liquid detergent compositions
PL324603A1 (en) Liquid cleaning compositions
PL324624A1 (en) Liquid cleaning compositions
AU1608695A (en) Liquid cleaning compositions
PL331645A1 (en) Pharmaceutic composition containing 4-oxobutanic acids
AU1894695A (en) Detergent compositions
AU1077200A (en) Novel chimeric polypeptide